Magnetic resonance imaging of brain structural and functional changes in cognitive impairment associated with Parkinson’s disease

Magnetic resonance imaging of brain structural and functional changes in cognitive impairment associated with Parkinson’s disease

Cognitive impairment is a critical non-motor symptom of Parkinson’s Disease (PD) that profoundly affects patients’ quality of life. Magnetic Resonance Imaging (MRI) has emerged as a valuable tool for investigating the structural and functional brain changes associated with cognitive impairment in PD...

Full description

Saved in:

Bibliographic Details
Main Authors:	Danna Cao, Jinhuan Yue, Zeyi Wei, Dong-Hong Huang, Xuchen Sun, Ke-Xuan Liu, Peng Wang, Fan Jiang, Xiaoling Li, Qinhong Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Parkinson’s disease cognitive impairment magnetic resonance imaging brain structure brain function
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2024.1494385/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Perspectives on resting-state functional magnetic resonance imaging research in vascular dementia
by: Jinhuan Yue, et al.
Published: (2025-07-01)

Capturing the Abnormal Brain Network Activity in Early Parkinsons Disease With Mild Cognitive Impairment Based on Dynamic Functional Connectivity
by: Guosheng Yi, et al.
Published: (2023-01-01)

Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiology
by: Frederick Clasen, et al.
Published: (2025-12-01)

Sequential patterning of dynamic brain states distinguish Parkinson’s disease patients with mild cognitive impairments
by: Aaron S. Kemp, et al.
Published: (2025-01-01)

Cognitive impairment in patients with Parkinson’s disease
by: I. A. Zhukova, et al.
Published: (2010-08-01)

Evaluation and fMRI Analysis of Cognitive and Language Impairment of Perinatally Acquired Left Brain Injury
by: Xiuyuan ZHENG, et al.
Published: (2015-12-01)

Subregional analysis of the amygdala, thalamus, and hypothalamus at the pre-decline stage in Parkinson’s disease with later cognitive impairment
by: Kazuhide Seo, et al.
Published: (2025-05-01)

A Comparison of the Brain Parameters of Thais with Normal Cognition, Mild Cognitive Impairment, and Dementia
by: Pariwat Wisetwongsa, et al.
Published: (2025-01-01)

The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
by: Angenelle Eve Rosal, et al.
Published: (2025-02-01)

Different rs-fMRI Data Processing Methods in the Study of Vascular Cognitive Impairment
by: Ying GUAN, et al.
Published: (2019-02-01)

Nucleus Basalis of Meynert Volume and Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation of the Subthalamic Nucleus
by: Vibuthi Sisodia, et al.
Published: (2025-06-01)

Progress of deep brain stimulation for Parkinson's disease
by: BAI Yu⁃tong, et al.
Published: (2025-01-01)

Charcot and vascular Parkinsonism
by: Hélio A. G. Teive, et al.

Visual detection of regional brain hypometabolism in cognitively impaired patients is independent of positron emission tomography-magnetic resonance attenuation correction method
by: Ana Franceschi, et al.
Published: (2018-07-01)

Effects of Goreisan in the Perioperative Period of Subthalamic Deep Brain Stimulation in Parkinson's Disease
by: Hiroyuki Kajikawa, et al.
Published: (2024-10-01)

Iron induces blood-brain barrier alteration contributing to cognitive impairment in β-thalassaemia mice
by: Parinda Jamrus, et al.
Published: (2025-01-01)

A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
by: Yang Luo, et al.
Published: (2025-02-01)

Association of individual-based morphological brain network alterations with cognitive impairment in type 2 diabetes mellitus
by: Die Shen, et al.
Published: (2025-01-01)

Correlation between change in choroid plexus volume and cognitive function in patients with Parkinson’s disease
by: ZHOU Suyi, et al.
Published: (2025-04-01)

Compound impact of cognitive and physical decline: A qualitative interview study of people with Parkinson's and cognitive impairment, caregivers and professionals
by: Jennifer S. Pigott, et al.
Published: (2024-02-01)

Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions
by: Ristić-Baloš Dragana, et al.
Published: (2013-01-01)

Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism
by: Wei Zhou, et al.
Published: (2025-07-01)

Changes in the Parietal Lobe Subregion Volume at Various Stages of Alzheimer’s Disease and the Role in Cognitively Normal and Mild Cognitive Impairment Conversion
by: Fang Lu, et al.
Published: (2025-01-01)

Correlations of vascular cognitive impairment with brain-derived neurotrophic factor and trace elements
by: Zhou Rong, et al.
Published: (2025-01-01)

Predictive value of serum neurofilament light chain for cognitive impairment in Parkinson’s disease
by: Lihua Gu, et al.
Published: (2024-12-01)

Deep brain stimulation on cognition in epilepsy: A concentration on learning and memory
by: Beibei Shen, et al.
Published: (2024-12-01)

Buffering brain aging: education moderates language impairment in Parkinson's disease
by: Minchul Kim, et al.
Published: (2025-08-01)

Increased Blood-Brain Barrier Permeability and Cognitive Impairment in Patients With ESKD
by: Mickaël Bobot, et al.
Published: (2024-10-01)

Preoperative structural networks based on DTI predicts initial subthalamic nucleus stimulation outcome in parkinson’s disease
by: Xiaoyue Wang, et al.
Published: (2025-08-01)

Possibilities of magnetic resonance imaging in SWI mode in differential diagnosis of brain gliomas (G3–G4) and primary lymphomas
by: D. V. Sashin, et al.
Published: (2020-07-01)

Patient’s intellectual and memory impairments before and after resection of brain glioma
by: V. Yu. Cherebillo, et al.
Published: (2019-11-01)

Reversible brain damage following acute organic solvents' poisoning determined by magnetic resonance
by: Dujmović Irena, et al.
Published: (2005-01-01)

Association of plasma homocysteine with cognitive impairment in patients with Parkinson’s disease
by: Yan Xiao, et al.
Published: (2024-12-01)

The Microbiome-Gut-Brain Axis, Nutrition and Parkinson’s Disease
by: Jevgenija Guk, et al.
Published: (2024-03-01)

Multiparameter resting-state functional magnetic resonance imaging as an indicator of neuropsychological changes in Binswanger’s disease with mild cognitive impairment
by: Haiyi Zhang, et al.
Published: (2025-02-01)

A prospective study of cognitive impairment in Parkinson’s disease: clinical, neuropsychological, and neuroimaging correlates
by: Ahmed A. Gaballa, et al.
Published: (2025-06-01)

A predictive model of cognitive impairment in Parkinson's disease based on multivariate logistic regression
by: BA Mengru, et al.
Published: (2024-06-01)

The Correlations between Volume Loss of Temporal and Subcortical Functional Subregions and Cognitive Impairment at Various Stages of Cognitive Decline
by: Fang Lu, et al.
Published: (2024-12-01)

Possibilities of Magnetic Resonance Imaging of the Brain in Infantile Cerebral Palsy
by: Anna N. Belova, et al.
Published: (2018-10-01)

A study on the exploration of mild cognitive impairment in Parkinson’s disease based on decision-making cognitive computing
by: Shouqiang Huang, et al.
Published: (2025-01-01)